FREE COMMUNICATION 1

   
08:00 - 09:30     CAPITAL SUITE 7/12


Free Communication Session 1 + Mini Lecture

CKD inflammation and aging

Chairs: Jill Norman, London, UK
             Boleslaw Rutkowski, Gdansk, Poland

Mini lecture
The inflamed uremic phenotype - a mediator of premature aging
Peter Stenvinkel, Stockholm, Sweden

FREE COMMUNICATIONS

FO001
INSULIN SECRETORY DEFECT IN A MOUSE MODEL OF CHRONIC KIDNEY DISEASE
Laetitia Koppe, Elsa Nyam, Valentine Moulle, Vincent Poitout, CR CHUM, Montreal Diabetes Research Center, Montréal, QC, CANADA.

FO002
MEDIATION ANALYSIS OF PRO-INFLAMMATORY DIETS AND KIDNEY FUNCTION IN TWO
COMMUNITY-BASED COHORTS OF ELDERLY
Hong Xu1, Per Sjögren2, Johan Ärnlöv3, Tanushree Banerjee4, Tommy Cederholm2, Ulf Risérus2, Bengt Lindholm1, Lars Lind3, Juan Jesús Carrero1, 1Karolinska Instituet, Div Renal Medicine and Baxter Novum, Stockholm, SWEDEN, 2Uppsala Univ, Dept Public Health and Caring Sciences, Uppsala, SWEDEN, 3Uppsala Univ, Dept Medical Sciences, Uppsala, SWEDEN, 4Univ California, Div General Internal Medicine, Dept Medicine, California, CA.

FO003
SOLUBLE CD14, A MARKER OF ENDOTOXEMIA, IS ASSOCIATED WITH SURVIVAL AND CARDIOVASCULAR DISEASE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
Ruben Poesen1, Ian Barrows2, Ali Ramezani2, Pieter Evenepoel1, Kathleen Claes1, Björn Meijers1, Dominic Raj2, 1Univ Hosp Leuven, Nephrology, Leuven, BELGIUM, 2George Washington Univ, Renal Diseases and Hypertension, Washington, DC, WA.

FO004
CITRATE BUFFERS INCREASE DIALYSIS EFFICIENCY AND REDUCE BIOMARKERS OF INFLAMMATION, ENDOTHELIAL DYSFUNCTION AND VASCULAR CALCIFICATION: A MONOCENTRIC TRANSLATIONAL STUDY
Sergio Dellepiane1,2, Vincenzo Cantaluppi1,2, Cesare Guarena2, Davide Medica1, Tiziana Musso3, Gianluca Leonardi2, Marinella Talaia2, Massimo Gai2, Patrizia Anania2, Luigi Biancone1,2, 1Turin Univ, Medical Science, Torino, ITALY, 2Nefrologia, Dialisi e Trapianto - AOU Città Salute e Scienza Torino, Internal Medicine, Torino, ITALY, 3Microbiologia e Virologia - AOU Città Salute e Scienza Torino, Medicina di Laboratorio, Torino, ITALY.

FO005
SERUM AMYLOID A (SAA) AND HIGH DENSITY LIPOPROTEINS (HDL) INTERACTION AND CARDIOVASCULAR RISK IN RENAL PATIENTS
Stephen Zewinger1, Thimoteus Speer1, Christiane Drechsler2, Marcus E. Kleber3, Alexander Dressel3, Julia Riffel1, Marlene Lehmann1, Chantal Kopecky4, Marcus D. Säemann4, Philipp M. Lepper5, Günther Silbernagel6, Hubert Scharnagl7, Andreas Ritsch8, Ulrich Laufs9, Christoph Wanner2, Danilo Fliser1, Winfried März3,10, 1Saarland Univ Medical Centre, Dept Internal Medicine IV, Homburg/Saar, GERMANY, 2Univ Würzburg, Dept Medicine, Div Nephrology, Würzburg, GERMANY, 3Univ Heidelberg, Mannheim Medical Fac, Medical Clinic V, Mannheim, GERMANY, 4Medical Univ Vienna, Dept Internal Medicine III, Vienna, AUSTRIA, 5Saarland Univ Medical Centre, Dept Internal Medicine V, Homburg/ Saar, GERMANY, 6Inselspital Bern, Dept Angiology, Swiss Cardiovascular Center, Bern, SWITZERLAND, 7Medical Univ Graz, Clinical Inst Medical and Chemical Lab Diagnostics, Graz, AUSTRIA, 8Innsbruck Medical Univ, Dept Internal Medicine I, Innsbruck, AUSTRIA, 9Saarland Univ Medical Centre, Dept Internal Medicine III, Homburg/Saar, GERMANY, 10Synlab, Mvz, Leinfelden-Echterdingen, GERMANY.

 

back to the timetable